ARCHIVES

In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online

This article is from The Cancer Letter archive.

Vol. 25 No. 05 | February 5, 1999

Download PDF Visit The Full Archive

Related Articles

In Brief: Melanoma Precursors Consensus Conference Planned, DRCC Board Raps Centers Budget Cut

May 20, 1983

In congress: Scientists Seek Closing NIH Office Of Alternative Medicine

July 11, 1997

FDA, NIH Streamline Approvals For Gene Therapy Studies

June 16, 1995

NCI Directory Delayed

January 27, 1984

Moffitt Ends Pilot Study Based On Duke Test, Says Action Unrelated

October 23, 2009

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

July 25, 2014